Correlations between the viscoelastic behavior of pyrene-labeled associative polymers and the associations of their fluorescent hydrophobes.

The viscoelastic behavior of a series of three pyrene-labeled hydrophobically modified alkali swellable emulsion copolymers (Py-HASEs) was investigated. All Py-HASEs thickened the aqueous solutions with viscosities orders of magnitude larger than that of a HASE control which displayed no pyrene hydrophobe. This fact demonstrated that the pyrene molecule is a good hydrophobe for associative thickeners such as HASEs. The Py-HASE solutions exhibited shear thinning, whose magnitude was found to increase with increasing pyrene content. A large shear-thinning effect indicates that a large fraction of the elastically active cross-links has been severed. Fluorescence measurements on the Py-HASEs confirmed that the smaller the pyrene content of the Py-HASE, the more intermolecular associations it formed, in agreement with the results obtained by rheology. Above the overlap concentration of the polymers, the zero-shear viscosity of the Py-HASE solutions increased steeply with increasing polymer concentration. The onset concentration where viscosity increases matches the onset concentration where intermolecular associations are being formed, as probed by fluorescence. Oscillatory rheological measurements were carried out to determine the terminal relaxation time, Td, and the storage modulus at the infinite time limit, G0, of the Py-HASE network. G0 was found to increase with decreasing pyrene contents, indicating that Py-HASEs with lower pyrene contents exhibited a higher density of elastically active chains. This result is in agreement with the trends obtained by the fluorescence and steady-state rheology measurements. A model is suggested that accounts for the fluorescence and rheology results.

Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients.

In ethnic heterogeneous California, complete genetic information is currently lacking to build solid population-based cystic fibrosis (CF) screening programs because a large proportion of mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR/ABCC7) are still unknown, especially in non-Caucasian patients. A total of 402 [46 African American+356 Hispanic] Hispanic and African American patients from California CF patient registry were included in this study. Patients with at least one unidentified mutant allele were asked to donate blood samples for further analysis, first by Genzyme Genetics for a panel of 87 known mutations, followed by temporal temperature gradient gel electrophoresis (TTGE) scanning of the entire coding exons of CFTR gene. A total of eight novel mutations; one missense mutation, one splice-site mutation and six frame-shift mutations were identified. In addition to the eight novel mutations, 20 [corrected] distinct rare mutations that are not in the current available commercial mutation panels were identified by TTGE. The overall detection rate was raised to 95.7% for African American and 94.5% for Hispanic. The discovery of recurrent rare and novel mutations improves the diagnosis and care of persons with CF and improves our ability to adequately and equitably provide screening and genetic counseling services to non-Caucasians.